Industry: Service & Software
Published Date: 2026-03-06
Pages: 122 Pages
Report ld: 6023714
Request Sample
Customized Report
Plasma Fractionation Technology Market Size(US$)

CAGR 2026-2032
7.5%
Market Size,2032
USD 62,130
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Plasma Fractionation Technology market was valued at US$ 37710 million in 2025 and is anticipated to reach US$ 62130 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.
North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.
This report delivers a comprehensive overview of the global Plasma Fractionation Technology market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Plasma Fractionation Technology. The Plasma Fractionation Technology market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Plasma Fractionation Technology market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Plasma Fractionation Technology manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Plasma Fractionation Technology companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Fractionation Technology Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Plasma Fractionation Technology Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma Fractionation Technology Market Perspective (2021–2032)
2.2 Global Plasma Fractionation Technology Growth Trends by Region
2.2.1 Global Plasma Fractionation Technology Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Plasma Fractionation Technology Historic Market Size by Region (2021–2026)
2.2.3 Plasma Fractionation Technology Forecasted Market Size by Region (2027–2032)
2.3 Plasma Fractionation Technology Market Dynamics
2.3.1 Plasma Fractionation Technology Industry Trends
2.3.2 Plasma Fractionation Technology Market Drivers
2.3.3 Plasma Fractionation Technology Market Challenges
2.3.4 Plasma Fractionation Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Fractionation Technology Players by Revenue
3.1.1 Global Top Plasma Fractionation Technology Players by Revenue (2021–2026)
3.1.2 Global Plasma Fractionation Technology Revenue Market Share by Players (2021–2026)
3.2 Global Top Plasma Fractionation Technology Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Plasma Fractionation Technology Revenue
3.4 Global Plasma Fractionation Technology Market Concentration Ratio
3.4.1 Global Plasma Fractionation Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Fractionation Technology Revenue in 2025
3.5 Global Key Players of Plasma Fractionation Technology Head Offices and Areas Served
3.6 Global Key Players of Plasma Fractionation Technology, Products and Applications
3.7 Global Key Players of Plasma Fractionation Technology, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Plasma Fractionation Technology Breakdown Data by Type
4.1 Global Plasma Fractionation Technology Historic Market Size by Type (2021–2026)
4.2 Global Plasma Fractionation Technology Forecasted Market Size by Type (2027–2032)
5 Plasma Fractionation Technology Breakdown Data by Application
5.1 Global Plasma Fractionation Technology Historic Market Size by Application (2021–2026)
5.2 Global Plasma Fractionation Technology Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Plasma Fractionation Technology Market Size (2021–2032)
6.2 North America Plasma Fractionation Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Plasma Fractionation Technology Market Size by Country (2021–2026)
6.4 North America Plasma Fractionation Technology Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasma Fractionation Technology Market Size (2021–2032)
7.2 Europe Plasma Fractionation Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Plasma Fractionation Technology Market Size by Country (2021–2026)
7.4 Europe Plasma Fractionation Technology Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Plasma Fractionation Technology Market Size (2021–2032)
8.2 Asia-Pacific Plasma Fractionation Technology Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Plasma Fractionation Technology Market Size by Region (2021–2026)
8.4 Asia-Pacific Plasma Fractionation Technology Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Plasma Fractionation Technology Market Size (2021–2032)
9.2 Latin America Plasma Fractionation Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Plasma Fractionation Technology Market Size by Country (2021–2026)
9.4 Latin America Plasma Fractionation Technology Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Fractionation Technology Market Size (2021–2032)
10.2 Middle East & Africa Plasma Fractionation Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Plasma Fractionation Technology Market Size by Country (2021–2026)
10.4 Middle East & Africa Plasma Fractionation Technology Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Plasma Fractionation Technology Introduction
11.1.4 Takeda Revenue in Plasma Fractionation Technology Business (2021–2026)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Plasma Fractionation Technology Introduction
11.2.4 CSL Revenue in Plasma Fractionation Technology Business (2021–2026)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Details
11.3.2 Grifols Business Overview
11.3.3 Grifols Plasma Fractionation Technology Introduction
11.3.4 Grifols Revenue in Plasma Fractionation Technology Business (2021–2026)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Plasma Fractionation Technology Introduction
11.4.4 Octapharma Revenue in Plasma Fractionation Technology Business (2021–2026)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Details
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Plasma Fractionation Technology Introduction
11.5.4 Kedrion Revenue in Plasma Fractionation Technology Business (2021–2026)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Details
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Plasma Fractionation Technology Introduction
11.6.4 LFB Group Revenue in Plasma Fractionation Technology Business (2021–2026)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Plasma Fractionation Technology Introduction
11.7.4 Biotest Revenue in Plasma Fractionation Technology Business (2021–2026)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Details
11.8.2 BPL Business Overview
11.8.3 BPL Plasma Fractionation Technology Introduction
11.8.4 BPL Revenue in Plasma Fractionation Technology Business (2021–2026)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Details
11.9.2 RAAS Business Overview
11.9.3 RAAS Plasma Fractionation Technology Introduction
11.9.4 RAAS Revenue in Plasma Fractionation Technology Business (2021–2026)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 CBPO Business Overview
11.10.3 CBPO Plasma Fractionation Technology Introduction
11.10.4 CBPO Revenue in Plasma Fractionation Technology Business (2021–2026)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Details
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Plasma Fractionation Technology Introduction
11.11.4 Hualan Bio Revenue in Plasma Fractionation Technology Business (2021–2026)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Details
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Plasma Fractionation Technology Introduction
11.12.4 Tiantan Bio Revenue in Plasma Fractionation Technology Business (2021–2026)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Details
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Plasma Fractionation Technology Introduction
11.13.4 Shuanglin Bio Revenue in Plasma Fractionation Technology Business (2021–2026)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Details
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Plasma Fractionation Technology Introduction
11.14.4 Boya Bio Revenue in Plasma Fractionation Technology Business (2021–2026)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Details
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Plasma Fractionation Technology Introduction
11.15.4 Yuanda Shuyang Revenue in Plasma Fractionation Technology Business (2021–2026)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Details
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Plasma Fractionation Technology Introduction
11.16.4 Weiguang Bio Revenue in Plasma Fractionation Technology Business (2021–2026)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Details
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Plasma Fractionation Technology Introduction
11.17.4 Nanyue Bio Revenue in Plasma Fractionation Technology Business (2021–2026)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Details
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Plasma Fractionation Technology Introduction
11.18.4 KM Biologics Revenue in Plasma Fractionation Technology Business (2021–2026)
11.18.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Plasma Fractionation Technology market size was US$ 37710 million in 2025 and is forecast to reach a readjusted size of US$ 62130 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 108
USD 4250.00
(Single User License)
The global market for Plasma Fractionation Technology was estimated to be worth US$ 37710 million in 2025 and is projected to reach US$ 62130 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 131
USD 3950.00
(Single User License)
The global Plasma Fractionation Technology market size was US$ 35330 million in 2024 and is forecast to a readjusted size of US$ 58200 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-11-17
Pages: 105
USD 4250.00
(Single User License)
The global Plasma Fractionation Technology market is projected to grow from US$ 35330 million in 2024 to US$ 58200 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 154
USD 4900.00
(Single User License)
The global market for Plasma Fractionation Technology was valued at US$ 35330 million in the year 2024 and is projected to reach a revised size of US$ 58200 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-02-04
Pages: 98
USD 2900.00
(Single User License)
The global market for Plasma Fractionation Technology was estimated to be worth US$ 35330 million in 2024 and is forecast to a readjusted size of US$ 58200 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-02-04
Pages: 137
USD 3950.00
(Single User License)
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Published Date: 2024-10-17
Pages: 125
USD 4350.00
(Single User License)
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Published Date: 2024-10-17
Pages: 125
USD 3950.00
(Single User License)
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Published Date: 2024-10-17
Pages: 149
USD 4900.00
(Single User License)
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Published Date: 2024-10-17
Pages: 99
USD 2900.00
(Single User License)
The global Plasma Fractionation Technology market size was US$ 37710 million in 2025 and is forecast to reach a readjusted size of US$ 62130 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 108
The global market for Plasma Fractionation Technology was estimated to be worth US$ 37710 million in 2025 and is projected to reach US$ 62130 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-03-06
Pages: 131
The global Plasma Fractionation Technology market size was US$ 35330 million in 2024 and is forecast to a readjusted size of US$ 58200 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-11-17
Pages: 105
The global Plasma Fractionation Technology market is projected to grow from US$ 35330 million in 2024 to US$ 58200 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 154
The global market for Plasma Fractionation Technology was valued at US$ 35330 million in the year 2024 and is projected to reach a revised size of US$ 58200 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-02-04
Pages: 98
The global market for Plasma Fractionation Technology was estimated to be worth US$ 35330 million in 2024 and is forecast to a readjusted size of US$ 58200 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-02-04
Pages: 137
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Published: 2024-10-17
Pages: 125
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Published: 2024-10-17
Pages: 125
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Published: 2024-10-17
Pages: 149
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Published: 2024-10-17
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now